| N=44 |
N (%) |
| Male |
21 (47.7) |
| Age, years (mean±SD) |
58.34±13.41 |
| Risk factors for PE |
Recent surgery |
21 (47.7) |
| Malignancy |
6 (13.6) |
| Immobilisation |
3 (6.8) |
| Hypercoagulability |
3 (6.8) |
| Recent trauma/fractures |
3 (6.8) |
| Idiopathic |
8 (18.2) |
| Main symptoms |
Chest pain |
8 (18.2) |
| Palpitations |
4 (9.1) |
| Dyspnoea |
13 (29.5) |
| Presyncope/syncope |
19 (43.2) |
| Cardiac arrest |
3 (6.8) |
| Contraindications for thrombolysis |
Absolute |
4 (9.1) |
| Relative |
30 (68.2) |
| Clinical presentation |
Shock |
11 (25) |
| Hypotension |
10 (22.7) |
| Echocardiographic evidence of RVD |
38 (86.4) |
| PESI class 5 |
26 (59.1) |
| PESI class 4 |
15 (34.1) |
| Echocardiography |
Right ventricular dilation (RV/LV >1) |
38 (86.4) |
| Right ventricular hypokinesia |
23 (52.3) |
| Tricuspid regurgitation |
10 (22.7) |
| Abnormal interventricular septal motion |
20 (45.5) |
| Computer tomography |
41 (93.2) |
| Saddle emboli in CT angiography |
36 (81.8) |
| DVT by sonographic examination |
32 (72.7) |
| Troponin I >0.01 ng/mL at presentation |
19 (43.2) |
| D-dimer >500 ng/mL at presentation |
41 (93.2) |
| IVC filter deployed |
31 (70.5) |
| Local infusions of fibrinolytic agent |
40 (90.9) |
| ART treatment for DVT and PE simultaneously |
19 (43.2) |
| ART: AngioJet rheolytic thrombectomy; DVT: deep vein thrombosis; IVC: inferior vena cava; PE: pulmonary embolism; PESI: pulmonary embolism severity index; RVD: right ventricular dysfunction |
